85 related articles for article (PubMed ID: 15890978)
1. A bittersweet modification: O-GlcNAc and cardiac dysfunction.
Jones SP
Circ Res; 2005 May; 96(9):925-6. PubMed ID: 15890978
[No Abstract] [Full Text] [Related]
2. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart.
Hu Y; Belke D; Suarez J; Swanson E; Clark R; Hoshijima M; Dillmann WH
Circ Res; 2005 May; 96(9):1006-13. PubMed ID: 15817886
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.
Zachara NE; Hart GW
Biochim Biophys Acta; 2004 Jul; 1673(1-2):13-28. PubMed ID: 15238246
[TBL] [Abstract][Full Text] [Related]
5. The O-GlcNAcase theory of diabetes: commentary on a candidate gene for diabetes.
Kudlow JE
Mol Genet Metab; 2002; 77(1-2):1-2. PubMed ID: 12359123
[No Abstract] [Full Text] [Related]
6. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.
Wells L; Gao Y; Mahoney JA; Vosseller K; Chen C; Rosen A; Hart GW
J Biol Chem; 2002 Jan; 277(3):1755-61. PubMed ID: 11788610
[TBL] [Abstract][Full Text] [Related]
7. The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl-beta-d-glucosaminidase that contain amino acid residues essential for enzymatic activity.
Lee TN; Alborn WE; Knierman MD; Konrad RJ
Biochem Pharmacol; 2006 Sep; 72(6):710-8. PubMed ID: 16844097
[TBL] [Abstract][Full Text] [Related]
8. [Role of O-GlcNAc in signal transduction].
Li JL; Ma L
Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):373-5. PubMed ID: 12650083
[No Abstract] [Full Text] [Related]
9. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors.
Macauley MS; Whitworth GE; Debowski AW; Chin D; Vocadlo DJ
J Biol Chem; 2005 Jul; 280(27):25313-22. PubMed ID: 15795231
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation of connexin 40: a sweet connection between diabetes and endothelial cell dysfunction? Focus on "O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice".
Issad T
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C590-2. PubMed ID: 26377315
[No Abstract] [Full Text] [Related]
11. Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates.
Lazarus BD; Love DC; Hanover JA
Glycobiology; 2006 May; 16(5):415-21. PubMed ID: 16434389
[TBL] [Abstract][Full Text] [Related]
12. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
Whelan SA; Hart GW
Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
[TBL] [Abstract][Full Text] [Related]
13. High-fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen-activated protein kinase activation and apoptosis.
Li SY; Liu Y; Sigmon VK; McCort A; Ren J
Diabetes Obes Metab; 2005 Jul; 7(4):448-54. PubMed ID: 15955132
[TBL] [Abstract][Full Text] [Related]
14. Ataxin-10 interacts with O-linked beta-N-acetylglucosamine transferase in the brain.
März P; Stetefeld J; Bendfeldt K; Nitsch C; Reinstein J; Shoeman RL; Dimitriades-Schmutz B; Schwager M; Leiser D; Ozcan S; Otten U; Ozbek S
J Biol Chem; 2006 Jul; 281(29):20263-70. PubMed ID: 16714295
[TBL] [Abstract][Full Text] [Related]
15. A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans.
Lehman DM; Fu DJ; Freeman AB; Hunt KJ; Leach RJ; Johnson-Pais T; Hamlington J; Dyer TD; Arya R; Abboud H; Göring HH; Duggirala R; Blangero J; Konrad RJ; Stern MP
Diabetes; 2005 Apr; 54(4):1214-21. PubMed ID: 15793264
[TBL] [Abstract][Full Text] [Related]
16. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells.
Hanover JA; Lai Z; Lee G; Lubas WA; Sato SM
Arch Biochem Biophys; 1999 Feb; 362(1):38-45. PubMed ID: 9917327
[TBL] [Abstract][Full Text] [Related]
17. Structure and mechanism of a bacterial beta-glucosaminidase having O-GlcNAcase activity.
Dennis RJ; Taylor EJ; Macauley MS; Stubbs KA; Turkenburg JP; Hart SJ; Black GN; Vocadlo DJ; Davies GJ
Nat Struct Mol Biol; 2006 Apr; 13(4):365-71. PubMed ID: 16565725
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate.
Kim EJ; Kang DO; Love DC; Hanover JA
Carbohydr Res; 2006 Jun; 341(8):971-82. PubMed ID: 16584714
[TBL] [Abstract][Full Text] [Related]
19. Analysis of MGEA5 on 10q24.1-q24.3 encoding the beta-O-linked N-acetylglucosaminidase as a candidate gene for type 2 diabetes mellitus in Pima Indians.
Farook VS; Bogardus C; Prochazka M
Mol Genet Metab; 2002; 77(1-2):189-93. PubMed ID: 12359146
[TBL] [Abstract][Full Text] [Related]
20. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development.
Whisenhunt TR; Yang X; Bowe DB; Paterson AJ; Van Tine BA; Kudlow JE
Glycobiology; 2006 Jun; 16(6):551-63. PubMed ID: 16505006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
